|
Product Description
Primary glomerulonephritis is one of the most frequent renal diseases, and a main cause of end-stage kidney disease. Glomerulonephritis has multiple subtypes, each with different physiopathologies, clinical presentations, and management requirements, which makes treatment difficult. As a complex set of diseases, the choice of symptomatic and specific treatment is critical to ameliorating the relentless course of glomerulonephritis.Focusing on all aspects of primary glomerulonephritis, from their epidemiologies and classification, to their pathogenesis and treatment, this third edition of Treatment of Primary Glomerulonephritis has been fully updated to include the latest research and evidence-based practice. With a strong emphasis on drugs used for both symptomatic and specific treatments, mechanisms of action, effectiveness, and potential toxicity are considered for therapeutic strategies in the different
subtypes of primary glomerulonephritis.
Each chapter follows a clear and logical format, allowing easy access to key information. Featuring over 20 full-colour histological images of different diseases to aid diagnosis, and with commentary from internationally recognised experts in the field, this new edition is an essential resource for all practising or academic clinical nephrologists.
Customers Who Bought This Item Also Bought
- Kidney Transplant Management: A Guide to Evaluation and Comorbidities
- Handbook of Chronic Kidney Disease Management
- Mayo Clinic Internal Medicine Board Review (Mayo Clinic Scientific Press)
- Comprehensive Clinical Nephrology E-Book
- Quick Guide to Kidney Transplantation
- Onco-Nephrology E-Book
- Nephrology Secrets E-Book
- Pocket Nephrology (Pocket Notebook Series)
- Handbook of Kidney Transplantation
- Brenner and Rector's The Kidney E-Book
*If this is not the "Treatment of Primary Glomerulonephritis (Oxford Clinical Nephrology Series)" product you were looking for, you can check the other results by clicking this link. Details were last updated on Dec 23, 2024 18:26 +08.